Angel Group of Companies has reacted to the Food and Drugs Authority (FDA) directive asking them to recall Adonko Bitters, an alcoholic beverage from the market.
According to the company, it was surprising that the FDA which approved the product would turn around and question its quality and safety mechanism.
The FDA last Thursday ordered Angel Group of Companies to recall the product from the market for contravening the Authority’s code on sale and advertisement of alcoholic beverages.
The Authority further slapped a fine of GH¢25,000 on the company following investigations into circumstances that led to the passing out of dozens of youth and minors at the Baba Yara Sports Stadium in Kumasi after an Easter Monday concert.
Read also: FDA orders recall of Adonko Bitters over drunken youth
At a press conference Monday, the Marketing Manager for the drink, Samuel Yaw Amankwah, however, appealed to the FDA to reconsider its decision to suspend its registration and advertisement license and that it was committed to cooperate with investigations.
According to him, while the event was aimed at rewarding loyal clients of Adonko Bitters, it was difficult to determine the ages of the revellers at the gates since those who came appeared to be of age.
He noted that the company with its “unblemished reputation” would not have deliberately offered alcohol to minors.
Mr Amankwah also noted that the company’s manufacturing practices and quality monitoring systems remained as thoroughly examined and approved by the FBA and that the alleged abuse of the product during the event “was completely unconnected to the safety and quality of Adonko Bitters.”
“We also assure the FDA of our full commitment and cooperation with the ongoing investigation even though we are certain that the outcome will confirm the contents of the product remains what the FDA approved,” he said.
Angel Group of Companies has reacted to the Food and Drugs Authority (FDA) directive asking them to recall Adonko Bitters, an alcoholic beverage from the market.
According to the company, it was surprising that the FDA which approved the product would turn around and question its quality and safety mechanism.
Read Full Story
Facebook
Twitter
Pinterest
Instagram
Google+
YouTube
LinkedIn
RSS